| Stage | INFU | % of rev | KEQU | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $37M | 100.00% | $66M | 100.00% | KEQU ×1.80 |
| Gross profit | $21M | 57.98% | $20M | 29.61% | INFU +28.4pp |
| Operating income | $4M | 11.24% | $3M | 4.76% | INFU +6.5pp |
| Pre-tax income | $4M | 10.48% | $3M | 3.86% | INFU +6.6pp |
| Net income | $3M | 8.75% | $2M | 2.78% | INFU +6.0pp |
| Stage | INFU | KEQU | Gap · A − B |
|---|---|---|---|
| Revenue | $37M100.00% | $66M100.00% | KEQU ×1.80 |
| Gross profit | 57.98%$21M | 29.61%$20M | INFU +28.4pp |
| Operating income | 11.24%$4M | 4.76%$3M | INFU +6.5pp |
| Pre-tax income | 10.48%$4M | 3.86%$3M | INFU +6.6pp |
| Net income |
| 8.75%$3M |
| 2.78%$2M |
| INFU +6.0pp |
No disclosed counterparties: KEQU.
None